Overview
Employees
51-200
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 12, 2011 | LabCorp completes ORCH offer, extends deadline for remaining shares | LabCorp in April announced it would acquire Orchid in a deal to boost its identity testing offerings and give the company a presence in the United Kingdom, where Orchid already has operations. The deal was expected to close in May but the F... |
| Dec 8, 2011 | LabCorp gets FTC OK for $85M Orchid acquisition | The agreement with the FTC comes eight months after Burlington, North Carolina-based LabCorp announced it would acquire Orchid. The deal was intended to bolster LabCorp’s identity testing offerings while also giving the company a presence i... |
| Jul 18, 2011 | LabCorp’s $85M Orchid offer extended again; FTC continues its review of deal | LabCorp provides laboratory services nationwide through its network of more than 1,500 labs. But the company has said that it wants to generate more of its revenue from specialty tests. Orchid would also help with LabCorp’s ambitions for in... |
| Jun 16, 2011 | LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal | LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month. The Burlington, North Carolina-based diagnostics and laboratory se... |
| Apr 6, 2011 | DNA testing company Orchid to be acquired by LabCorp for $85M | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| LabCorp’s $85M Orchid offer extended again; FTC continues its review of deal | LabCorp (NYSE:LH) needs a little more time to close its $85 million acquisition of Orchid Cellmark (NASDAQ:ORCH). The Burlington, North Carolina-based provider of laboratory services said Monday it has extended its offer for Orchid as it co... | |
| LabCorp completes $85M acquisition of Orchid Cellmark | LabCorp (NYSE:LH), after waiting eight months for regulators’ blessings, had a speedy wrap up of its $85 million acquisition of DNA testing company Orchid Cellmark. Laboratory testing and diagnostics firm LabCorp secured the greater than 90... | |
| DNA testing company Orchid to be acquired by LabCorp for $85M | Diagnostic technologies and genomic testing company LabCorp will buy DNA testing services company Orchid Cellmark in a deal valued at $85.4 million. LabCorp (NYSE:LH) said that the definitive agreement calls for the Burlington, North Caroli... | |
| LabCorp offer to buy Orchid extended to July 15; FTC still reviewing deal | LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month. The Burlington, North Carolina-based diagnostics and laboratory se... |
Show more